Dermatology CE/CME Accreditation - Integrative Dermatology Symposium

August 21-24, 2025 | 25+ CME | Tucson, Arizona

CE/CME Accreditation

Earn up to 25 CME credits at IDS 2025 by completing 14 CME credits through pre-conference on-demand courses and 10 CME credits in person, plus 1 credit from the CEA-hosted session “Psoriasis and Obesity: Going Pound for Pound on Comprehensive, Patient-Centered Management” on August 21 at 5:30 PM.

Accreditation Statement

The 2025 Integrative Dermatology Symposium is approved for 24 credits of continuing medical education (CME) by Medical Education Resources, Inc. 10 CME credits in person and access an additional 14 CME credits online.

ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and LearnHealth. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT

Medical Education Resources designates this live activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSOCIATE CREDIT

Medical Education Resources has been authorized by the American Academy of Physician Associate (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 24 AAPA Category 1 CME Credits. Physician Associate should only claim credit commensurate with the extent of their participation.

NURSING CREDIT

Medical Education Resources designates this live activity for a maximum of 24 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 24 contact hours.

FOR NATUROPATHIC DOCTORS

The Integrative Dermatology Symposium is approved for 24 General credit(s) of continuing education credits by the American Association of Naturopathic Physicians.

As you know, CE approval by the AANP covers all states that regulate naturopathic physicians, except Oregon. Please note that as of January 2025, the Oregon Board of Naturopathic Medicine (OBNM) will no longer approve a CE Activity submitted to them by the CE Activity Host. Only the individual Oregon licensee can apply directly to OBNM for CE approval.

If you do have an Oregon licensed ND attend your event, you can notify them that the program has not been submitted for approval to the OBNM, and provide them with the information needed for them to apply for approval as an individual. The AANP can assist you with providing Oregon NDs the requisite materials.

FOR ACUPUNCTURISTS AND ORIENTAL MEDICINE PRACTITIONERS

The Integrative Dermatology Symposium is approved by the National Certification Commission for Acupuncture and Oriental Medicine and is applying for 24 PDA Points. NCCAOM® PDA Points Provider #9093.

Goal & Purpose

The annual Integrative Dermatology Symposium is designed to appeal to practitioners across disciplines. It will address emerging trends, and practical approaches to dermatology as practitioners assess and manage skin conditions and care. It is estimated that nearly one-third of the population is afflicted with a skin disorder. There is a great need for best practice sharing and cross-collaboration to support practitioners in the field and improve patient outcomes.

Target Audience

This live symposium is designed to meet the educational needs of:

Acupuncturists
Advanced Practice and Registered Nurses
Ayurveda Practitioners
Chiropractors
Dermatologists
Family Practice Physicians
Internists
Licensed Herbalists
Naturopathic Doctors
Nutrition Specialists
Osteopathic Doctors
Pediatricians
Physicians
Physician Assistants

Disclosure of relevant financial relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)Avita-Advisory Board
Grants/Research SupportAvita–Investigator in Clinical Trial

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
Codex Labs

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board) – Abbvie Inc., NextScience Inc., Novartis Inc., Pfizer Inc.
Employee / Owner – Learnskin
Grants/Research Support – Essity Inc., Next Science Inc., Sigvaris Inc., Vomaris Inc.
Ownership Interest / Stock Holder – Learnskin

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
Abbvie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Dermavant, Galderma, Incyte, Johnson and Johnson, Leo, Lilly, Novan, Pfizer, Sanofi-Regeneron, Verrica

Speakers’ Bureau
Abbvie, Arcutis, Dermavant, Galderma, Incyte, Johnson and Johnson, Lilly, Pfizer, Sanofi-Regeneron, Verrica

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
Hidramed Solutions Inc., Insmed Inc., NextScience Inc., Novartis Inc., UCB Inc., Vomaris Inc.

Grants/Research Support
Incyte Inc., Lily Inc., Medline Inc., Molnlyke Inc., Moonlake Inc., Novartis Inc., , Sigvaris Inc. Tissue Tech Inc., UCB Inc., Essity Inc.,
Next Science Inc., Sigvaris Inc., Vomaris Inc.

Ownership Interest / Stock Holder
LearnSkin

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
AbbVie, Alumis, Aslan, Amgen, Arcutis, Bristol Myers Squibb, Boehringer Ingelheim, Coval Biopharma, Dermavant, Eli Lilly,
Galderma, Incyte, Johnson & Johnson, KoBio Labs, LEO, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, and UCB.

Grants/Research Support
AbbVie, Alumis, Aslan, Amgen, Arcutis, Bristol Myers Squibb, Boehringer Ingelheim, Coval Biopharma, Dermavant, Eli Lilly,
Galderma, Incyte, Johnson & Johnson, KoBio Labs, LEO, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, and UCB.

Ownership Interest / Stock Holder
Eli Lilly, Pfizer

Speakers’ Bureau
AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Eli Lilly, Incyte, Johnson & Johnson, Ortho Dermatologics, Pfizer, Regeneron, Sanofi

No financial relationships to disclose.

Consulting Fees – Almirall
Speakers Bureau – Vyne Pharmaceuticals

Consulting Fees (e.g. Advisory Board) – Apogee, Arcutis, BI, Blueprint Medicines, BMS, Boxer Capital LLC, Institute for Systems Biology (ISB), Janssen, LEO, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, UCB Honorarium – Apogee, Arcutis, BI, Blueprint Medicines, BMS, Boxer Capital LLC, Institute for Systems Biology (ISB), Janssen, LEO, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, UCB
Royalty / Patent Holder – UpToDate (Royalty payment for authorship)
Speakers’ Bureau – BMS, BI, Regeneron, Sanofi, UCB

Advisory Board – Orasure
Consulting Fees – Almirall
Grants/Research – DNA Genotek, La Roche Posay, Leo Pharma, Ortho Dermatologics

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
AbbVie, Avita Medical, Beiersdorf, Canfield Scientific, Dior, Eli Lilly, Galderma, Incyte, Janssen Biotech, Kao USA, La Roche-Posay, L’Oreal, McGraw Hill, Pfizer, Sanofi, Takeda, Visual DX

Grants/Research Support
Pfizer

Honorarium
Speaker for CME credit: Beiersdorf, Medscape

Ownership Interest / Stock Holder
stock options: Visual DX

Royalty / Patent Holder
author royalties: McGraw Hill

Ownership Interest / Stock Holder – FemHealth; K’ept Health; Fleurissent Skin Care

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Arcutis, Beiersdorf, Biofrontera, Botanix, BMS, BI, Galderma, J&J, Journey, LaRoche-Posay, Leo, Lilly, Novartis, Ortho, Pfizer, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, and Verrica

Grants/Research Support
Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Arcutis, Beiersdorf, Biofrontera, Botanix, BMS, BI, Galderma, J&J, Journey, LaRoche-Posay, Leo, Lilly, Novartis, Ortho, Pfizer, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, and Verrica

Honorarium
Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Arcutis, Beiersdorf, Biofrontera, Botanix, BMS, BI, Galderma, J&J, Journey, LaRoche-Posay, Leo, Lilly, Novartis, Ortho, Pfizer, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, and Verrica

Speakers’ Bureau

Affiliations with Abbvie, Advanced Derm Solutions, Almirall, Arcutis, Beiersdorf, Biofrontera, Botanix, BMS, BI, Galderma, J&J, Journey, LaRoche-Posay, Leo, Lilly, Novartis, Ortho, Pfizer, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, and Verrica

Consulting Fees (e.g. Advisory Board) – AlumierMD, La Roche Posay, Cerave, Skinceuticals, Pierre Fabre, Sente, OneSkin, Estee Lauder
Honorarium – Rationale

Consulting Fees (e.g. Advisory Board)
Alphyn Biologics, AbbVie, Almirall, Amyris, Arcutis, ASLAN, Astria Therapeutics, Boston Skin Science, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosci, Dermavant, Eli Lilly, Galderma, Kenvue, LEO Pharma, Lipidor, L’Oreal, Merck,
Micreos, MyOR Diagnostics, Pelthos Therapeutics, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Soteri Skin, Stratum Biosciences, Sun Pharma, Theraplex, Thimble Health, UCB, Unilever, Verdant Scientific, Verrica, Yobee Care

Ownership Interest /Stock Holder – STOCK OPTIONS: Alphyn Labs, Codex Labs, Concerto Biosci, Soteri Skin, Stratum Biosciences, Thimble, Yobee Care, Verdant Scientific

Royalty /Patent Holder – Theraplex AIM

Speakers’ Bureau – AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oreal, MyOR Diagnostics, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica

Other – Board Member, National Eczema Association

Consulting Fees (e.g. Advisory Board) – Abbvie, Arcutis, Lilly, Sanofi, Regeneron, Incyte, Bristol Myer Squibb, Boehringer Ingelheim, Sun Pharma, UCB, Novartis
Honorarium – Abbvie, Arcutis, Lilly, Sanofi, Regeneron, Incyte, Bristol Myer Squibb, Boehringer Ingelheim, Sun Pharma, UCB, Novartis
Speakers’ Bureau – Abbvie, Arcutis, Lilly, Sanofi, Regeneron, Incyte, Bristol Myer Squibb, Sun Pharma, UCB, Novartis

Honorarium
Sofwave

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board) –
Nutritional Fundamentals for Health: Advisory Board, Speaker

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
Lumenis

Speakers’ Bureau
Speaker and consulting

Consulting Fees (e.g. Advisory Board)
Novartis, Sanofi, Bristol Myers Squibb, Arbonne, Trace Minerals, Codex Labs, Pfizer, Nutrafol, Lilly, Galderma, Incyte, Novartis, Arcutis, Abbvie, Leo, UCB, Sun and Regeneron Pharmaceuticals

Speakers’ Bureau
Sanofi, Bristol Myers Squibb, Pfizer, Lilly, Galderma, Incyte, Abbvie, Leo, UCB, Regeneron Pharmaceuticals

Consulting Fees (e.g. Advisory Board)
A4M-Director of Professional Development

Employee / Owner
NeuroPharm, Inc

No financial relationships to disclose.

Grants/Research Support: Eli-Lilly
Speakers’ Bureau: Regeneron-Sanofi

Consulting Fees (e.g. Advisory Board) –
Abbvie, Incyte, Novartis, UCB

Grants/Research Support –
Abbvie, Incyte, Novartis, UCB, Moonlake, Sanofi, Regeneron

Speakers’ Bureau – Abbvie, Novartis, UCB

No financial relationships to disclose.

Consulting Fees (e.g. Advisory Board)
AbbVie, Almirall, Altus Lab/cQuell, Alumis, Aristea Therapeutics, Dermavant, Bain Capital, Boehringer-Ingelheim, Apogee, Burt’s Bees, Dermira, Eli Lilly, Galderma, Genentech, GpSkin, Incyte, LEO Pharma, Menlo Therapeutics, MYOR, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, Skin Actives Scientific, SUN Pharma, UCB, Ceraclere

Speakers’ Bureau
AbbVie, Sanofi Genzyme/Regeneron, Novartis

Grants/Research Support
ET Browne

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

LearnHealth Inc. Stockholder

No financial relationships to disclose.

Course Participant Attestation

I understand that the information in this course presented by the Provider and/orInstructor(s) is for educational purposes only and should only be applied with appropriate clinical judgment and used by a trained and licensed practitioner. Governmental laws and regulations vary from region to region and the contents of this course vary in permissible usage. The participant is required to check their local, state, and federal laws and regulations regarding the practice requirements and scope of practice issues and the use of the information of this course including, but not limited to, theory, herbal medicine, and acupuncture. I acknowledge that NCCAOM does not endorse any specific treatment regimens of any kind. Furthermore, if I use any modalities or treatments taught in this course, I agree to waive, release, indemnify, discharge, and covenant not to sue NCCAOM from and against any liability, claims, demands, or causes of action whatsoever, arising out of any injury, loss, or damage that a person may sustain related to the use of the information in this course. I understand that this Release is governed by the laws of District of Columbia, U.S.A. and shall survive the termination or expiration of this course.

DISCLAIMER

The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of MER and LearnHealth Inc. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

August 21-24, 2025 | 25+ CME | Tucson, Arizona

CE/CME Accreditation​

Accreditation Statement

Goal & Purpose

Target Audience

Disclosure of relevant financial relationships

Name of Faculty

Reported Financial Relationship

Amy Branum

Ammar Ahmed

Anna Cabeda

Audrey Rutherford

Apple Bodemer

Brian Morrison

Hadar Lev-Tov

DeJarra Sims

Denine Rogers

Douglas Preston

David W Mandel

Elizabeth Swanson

Faranak Kamangar

Hadar Lev-Tov

Asmi Sanghvi

David Euler

Emma Norton

James B. LaValle

Jennifer Soung

James Song

Jonette Keri

Jason Ezra Hawkes

Jean McGee

Joseph Alban

Nada Elbuluk

Keira Barr

Meena Julapalli

Neal Bhatia

Patricia Farris

Peter Lio

Lakshi Alderdge

Martha Viera

Manuel Valdebran

Michael Traub

Rubaina Dang

Ronda Farah

Raja Sivamani

Sahar Swidan

Sarina Elmariah

Sonal Chaoudhary

Steven Daveluy

Sururat Coulibaly

Vivian Shi

Zoe Diana Draelos

Name of Content Manager

Reported Financial Relationship

Venita Sivamani

Mer Content Manager

Course Participant Attestation

DISCLAIMER

Join our newsletter for event updates

Join The List

CE/CME Accreditation